Last reviewed · How we verify
Colchicine Loading Dose
At a glance
| Generic name | Colchicine Loading Dose |
|---|---|
| Sponsor | Hillel Yaffe Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Perioperative Colchicine for TKA (PHASE4)
- COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction (PHASE2)
- Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (PHASE3)
- Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome (PHASE2)
- Colchicine After Electrocardioversion for Atrial Fibrillation (PHASE3)
- Colchicine's Efficacy in MI Patients: Comparing PCI and Non-Reperfusion Approaches (EARLY_PHASE1)
- The Effect of Colchicine on Inflammation in ACS Patients (PHASE3)
- Colchicine and Post-COVID-19 Pulmonary Fibrosis (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Colchicine Loading Dose CI brief — competitive landscape report
- Colchicine Loading Dose updates RSS · CI watch RSS
- Hillel Yaffe Medical Center portfolio CI